Early Treatment with Addition of Low Dose Prednisolone to Methotrexate Improves Therapeutic Outcome in Severe Psoriatic Arthritis

Psoriatic arthritis (PsA) is increasingly being recognized to cause progressive joint damage and disability. PsA unresponsive to non-steroidal anti-inflammatory drugs (NSAIDs), the conventional first-line choice of treatment, is usually managed with disease-modifying antirheumatic drugs (DMARDs) esp...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahajan, Vikram K, Sharma, Anju Lath, Chauhan, Pushpinder S, Mehta, Karaninder S, Sharma, Nand Lal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
E-Therapeutic Round
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667301/
https://www.ncbi.nlm.nih.gov/pubmed/23723489
http://dx.doi.org/10.4103/0019-5154.110847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667301/
https://www.ncbi.nlm.nih.gov/pubmed/23723489
http://dx.doi.org/10.4103/0019-5154.110847

Ejemplares similares